PEP
PEP is an acronym for Post Exposure Prophylaxis. PEP is a combination of antiretroviral medicine intended to reduce the risk of HIV infection if taken within 72 hours of an HIV exposure. PEP is an important tool in preventing HIV infection, but it is not a guarantee that someone exposed to HIV will not contract the virus. It is important to start taking PEP as soon as possible after an exposure. While taking PEP, you are advised to use other HIV prevention methods, such as using barriers with sexual partners, such as condoms, and using sterile syringes and other supplies when injecting substances.
​
There are two types of PEP:
nPEP stands for "non-occupational post exposure prophylaxis" and is intended to reduce the risk of HIV infection from a non-work related exposure. The preferred medicine for nPEP in adult and adolescent patients 13 and older is Truvada combined with Raltegravir, Dolutegravir, or Isentress. The medication is is taken 1-2 times daily for 28 days.
oPEP stands for "occupational post exposure prophylaxis" and is intended to reduce the risk of infection after a work place (typically in a healthcare setting) related exposure. Workplaces will havesafety protocols in place to assist employees in accessing post-exposure care.
